Short answer
CME Group (CME) filed an 8-K current report with the SEC on April 22, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q1 2026 results covered quarter ended March 31, 2026.
CME Group 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results covered quarter ended March 31, 2026
- Press release dated April 22, 2026 provides the financial results and investor-relevant figures
- Non-GAAP revenue, expenses, operating income, net income and EPS included alongside GAAP measures
- Reconciliations support comparison with prior reports, but non-GAAP metrics remain supplemental to GAAP results
Item EX-99.1 · Exhibit EX-99.1
- Q1 2026 record revenue $1.9B, up 14%, with adjusted EPS $3.36, up 20%, signaling strong operating leverage
- Record ADV 36.2M contracts, up 22%, with all six asset classes posting records and non-U.S. ADV up 30%
- Clearing and transaction fees reached $1.5B; market data revenue hit $224M, reinforcing broad-based transaction and recurring-data growth
- Cash $2.6B versus debt $3.4B after approximately $2.7B dividends and $536M share repurchases, highlighting substantial capital returns
- Average rate per contract fell to $0.652 from $0.686, creating a mix and pricing risk despite record volumes
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CME Group 8-K filings
Get the next CME 8-K as it lands
Follow CME for push alerts, or ask the research agent what this filing means.